Stocktoria

MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2020-11-20

MARAVAI LIFESCIENCES HOLDINGS, INC. statistics & valuation

Market cap$1.6B
P / S8.6×
P / B4.3×
Net margin-70.4%
Return on equity-35.1%
FCF margin-38.1%
Net debt$74.9M
Enterprise value USD$1.7B
Earnings yield EBIT/EV-12.8%
Return on capital-29.7%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
31.30% 22.80% 24.90% -41.20% -55.90% -70.40% 202020212022202320242025
Gross margin (%)
48.50% 41.80% 18.30% 202020212022202320242025
Operating margin (%)
42.20% 69.40% 65.00% -11.00% -90.90% -115.90% 202020212022202320242025
Return on equity (%)
57.50% 33.40% 24.30% -15.10% -25.10% -35.10% 202020212022202320242025
Shares outstanding
28.9M 257.8M 255.3M 131.9M 137.9M 144.4M 202020212022202320242025
Net debt ($)
$534.6M $530.6M -$104.7M -$50.8M -$26.5M $74.9M 202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
7.00% 9.50% 9.60% -8.00% -14.40% -17.00% 202020212022202320242025
Free cash flow margin (%)
44.60% 44.30% 58.80% 21.00% -8.60% -38.10% 202020212022202320242025
Debt / equity (×)
3.45× 0.97× 0.58× 0.66× 0.51× 0.78× 202020212022202320242025
EPS ($)
$2.36 $1.56 $1.67 -$0.90 -$1.05 -$0.90 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Gross margin18.3%41.8%48.5%———
Operating margin-115.9%-90.9%-11.0%65.0%69.4%42.2%
Net margin-70.4%-55.9%-41.2%24.9%22.8%31.3%
FCF margin-38.1%-8.6%21.0%58.8%44.3%44.6%
Return on assets-17.0%-14.4%-8.0%9.6%9.5%7.0%
Return on equity-35.1%-25.1%-15.1%24.3%33.4%57.5%
Debt / equity0.78×0.51×0.66×0.58×0.97×3.45×
Current ratio6.607.538.007.707.892.54

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.